Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.45 HKD
Change Today +0.03 / 0.40%
Volume 2.4M
2348 On Other Exchanges
Symbol
Exchange
OTC US
Hong Kong
As of 4:01 AM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for dawnrays pharmaceutical hold (2348)

Year over year, Dawnrays Pharmaceutical Holdings Ltd. has seen revenues shrink from CNY915.0M CNY to CNY783.8M CNY, though the company was able to grow net income from CNY153.1M CNY to CNY205.1M CNY. A reduction in the percentage of sales devoted to cost of goods sold from 55.93% to 41.32% was a key component in the bottom line growth in the face of falling revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
CNY
Dec 31
2012
CNY
Dec 31
2013
CNY
Dec 31
2014
CNY
4 Year
Trend
Revenues1,081.0856.5915.0783.8
TOTAL REVENUES1,081.0856.5915.0783.8
Cost of Goods Sold718.3532.1511.7323.9
GROSS PROFIT362.8324.4403.2459.9
Selling General & Admin Expenses, Total156.6157.8174.4160.4
Other Operating Expenses41.432.553.556.5
OTHER OPERATING EXPENSES, TOTAL198.0190.3227.9217.0
OPERATING INCOME164.7134.1175.4243.0
Interest Expense-2.2-3.8-3.6-2.8
Interest and Investment Income4.05.09.314.2
NET INTEREST EXPENSE1.81.25.711.4
Currency Exchange Gains (Loss)3.30.62.2--
Other Non-Operating Income (Expenses)9.27.85.64.2
EBT, EXCLUDING UNUSUAL ITEMS179.1143.7188.9258.5
Gain (Loss) on Sale of Investments0.11.00.10.4
EBT, INCLUDING UNUSUAL ITEMS179.2144.6189.0258.9
Income Tax Expense32.930.135.953.7
Earnings from Continuing Operations146.3114.5153.1205.1
NET INCOME146.3114.5153.1205.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS146.3114.5153.1205.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS146.3114.5153.1205.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2348:HK $7.45 HKD +0.03

2348 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2348.
View Industry Companies
 

Industry Analysis

2348

Industry Average

Valuation 2348 Industry Range
Price/Earnings 23.4x
Price/Sales 6.1x
Price/Book 3.8x
Price/Cash Flow 23.3x
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.